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SUMMARY
One of the challenges in the management of acute 
blood loss is to differentiate whether blood transfusion 
is required or not. The sole use of haemoglobin values 
might lead to unnecessary transfusion in individual cases. 
The suggestion is that mitochondrial oxygen tension 
can be used as an additional monitoring technique 
to determine when blood transfusion is required. 
In this case report, we report mitochondrial oxygen 
measurements in a patient with perioperative blood loss 
requiring blood transfusion.
BACKGROUND
Goal- directed management of perioperative blood 
loss remains a major challenge for clinicians. Acute 
anaemia resulting in inadequate oxygen supply 
should be avoided at all times, but currently, no 
specific endpoint for personalised transfusion medi-
cine is available. Perioperative insufficient oxygen 
delivery to tissues is an important determinant 
for postoperative complications such as stroke,1 
declined cognitive function,2 kidney injury3 and 
cardiac ischaemia.4 Tissue oxygenation relies on 
adequate oxygen delivery, which is predominantly 
maintained by the arterial oxygen saturation, 
haemoglobin concentration and cardiac output. 
Transfusion of allogeneic erythrocyte concentrates 
plays an important role in treating acute anaemia 
for the prevention of tissue hypoxia. However, 
allogeneic blood transfusion itself is not without 
risks and is an independent risk factor for increased 
mortality and morbidity.5 One of the challenges 
in the management of anaemia is to determine 
whether blood transfusion is required or not. 
Current transfusion guidelines recommend haemo-
globin levels as a trigger for red blood cell trans-
fusion.6 7 These guidelines are based on mean data 
and thus incorporate safety margins, which might 
lead to unnecessary transfusion in individual cases. 
Additionally, more physiologically based transfu-
sion triggers may enable optimisation and person-
alised treatment during the management of acute 
blood loss and may help in preventing transfusion- 
related complications like haemolytic reactions, 
transfusion- related acute lung injury, infections and 
transfusion- associated circulatory overload. In a 
recent study in haemodiluted pigs, mitochondrial 
oxygen tension (mitoPO2) was suggested as a useful 
parameter to distinguish whether blood transfusion 
is necessary or not.8 Given that the mitochondrion 
is the final destination of oxygen, it seems logical 
to use mitoPO2 as a measure for transfusion need. 
The mitoPO2 can be measured by the COMET 
(an acronym for Cellular Oxygen METabolism) 
measuring system (Photonics Healthcare, Utrecht, 
the Netherlands).9 The measurement is based on 
the principle of oxygen- dependent quenching 
of delayed fluorescence of protoporphyrin IX 
(PpIX).10 11 Application of the porphyrin precursor 
5- aminolevulinic acid (5- ALA) on the skin induces 
PpIX in the mitochondria where it acts as a mito-
chondrially located oxygen- sensitive dye.12 After 
photoexcitation with a pulse of green light, PpIX 
emits delayed fluorescence of which the lifetime 
is inversely related to the amount of oxygen. The 
technique is non- invasive and can be safely used 
in humans.13 14 In this case report, we report the 
results of mitochondrial oxygen measurements 
in a patient with major intraoperative blood loss 
requiring blood transfusion.
CASE PRESENTATION
A 69- year- old man with a history of diabetes 
mellitus (type II), hypertension and dyslipidaemia 
and a recent diagnosis of metastatic ascending colon 
carcinoma (cT4N2M1) required extensive surgery 
and hyperthermic intraperitoneal chemotherapy 
(HIPEC). His medication included metformin, 
gliclazide, enalapril and simvastatin. Preoperative 
abdominal, respiratory and cardiac examination 
were unremarkable. Preoperative haemoglobin 
levels were 93.5 g/L.
Prior to induction of anaesthesia, an epidural 
catheter was placed, and epidural analgesia (ropi-
vacaine/sufentanil) was given. For induction of 
anaesthesia, an intravenous bolus dose of propofol 
110 mg followed by rocuronium 50 mg was admin-
istered, together with a continuous infusion of 
remifentanil 9 µg/kg/hour. Anaesthesia was main-
tained using sevoflurane. Directly after induction of 
anaesthesia, a continuous infusion of noradrenalin 
(0.40–0.60 µg/kg/min) was necessary to maintain 
normal blood pressure values (mean arterial pres-
sure (MAP) >65 mm Hg) .
During surgery, extensive peritoneal carcinoma-
tosis was observed with a Peritoneal Carcinoma-
tosis Index of 16.15 The surgeons performed a low 
anterior resection and an omentectomy. Thereafter, 
warm mitomycin C (chemotherapeutic agent) was 
rinsed abdominally for 1.5 hours via three inflow 
and two outflow catheters. Finally, a previously 
constructing ileostomy was reversed, and a terminal 
colostomy was placed.
After 1 hour of coma, during the low anterior 
resection, an acute rapid blood loss of 2500 mL 
occurred. Resuscitation of blood loss was initially 
done using crystalloids and colloids (figure 1). 
Haemodynamic parameters were kept stable, 
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without the need for extra vasoactive medication. Blood trans-
fusion was started after haemoglobin levels dropped below 88.6 
g/L.
INVESTIGATIONS
In addition to the standard intraoperative monitoring consisting 
of invasive blood pressure measurements, peripheral oxygen 
saturation, 5- lead electrocardiography and temperature 
measurements, two additional monitoring systems were used 
during this operation: the COMET for monitoring mitochon-
drial oxygenation and the oxygen to see (O2C) (LEA Mediz-
intechnik, Giessen, Germany) for monitoring microcirculatory 
blood flow velocity, tissue oxygen saturation (StO2) and relative 
amount of recombinant haemoglobin (rHb) in the skin.16
For the COMET measurements, a 5- ALA patch was applied 
the evening before surgery. Directly after the induction of anaes-
thesia, the 5- ALA patch was removed, and the skin sensor of 
the COMET was fixated to the chest. COMET measurement 
was performed during surgery with an interval of one measure-
ment per minute. The O2C probe was placed on the skin of 
the sternum next to the COMET measurement probe providing 
semicontinuous readings.
OUTCOME AND FOLLOW-UP
The mitoPO2 value started around 70 mm Hg and slowly 
declined in the first hour, parallel to StO2, to reach values 
around 50–60 mm Hg. After approximately 1 hour of operation 
time, a sudden blood loss of 2.5 L occurred. Initially, adequate 
haemodynamic status was ensured by infusion of crystalloids 
and colloids resulting in haemodilution and acute anaemia. Due 
to anaemia, oxygen delivery to the tissues decreased, accompa-
nied by declining microvascular and mitochondrial parameters, 
while other parameters such as MAP, StO2, rHb and lactate levels 
did not change during the ongoing blood loss. Heart rate and 
capillary blood flow did show a response to the bleeding but 
at a later stage than mitoPO2. Directly after resuscitation with 
red blood cells, a rapid increase of mitoPO2 was observed, with 
mitoPO2 values restored from below 10 mm Hg to up to 40 mm 
Hg (figure 1).
After surgery, the patient was transferred to the intensive 
care unit (ICU), and discharge from the ICU to a surgical ward 
was possible after 2 days. The stay in the surgical ward was 
complicated by a paracolic fluid collection, which was surgi-
cally drained. After a further trouble- free recuperation, the 
patient was released from the hospital 15 days after surgery. 
Eight months later, a CT scan diagnosed extensive recurrence of 
disease, eliminating curative treatment options. Unfortunately, 
the patient died 1 year later from the consequences of his illness.
DISCUSSION
In this case report, we show mitoPO2 use during acute periopera-
tive blood loss and propose mitoPO2 as an additional monitoring 
parameter for perioperative transfusion management.
In the current literature, there is controversy regarding the 
transfusion of blood components in oncological surgery. As early 
as in the 1980s, the effect of blood transfusion on malignancy 
recurrence rate was noted.17 These findings were based on simple 
bivariate correlation without the adjustment of confounders. The 
correlation between blood transfusion and malignant recurrence 
rate became less obvious with the introduction of new statistical 
techniques whereby confounding factors were included in the 
analysis.18 19 Although the negative effect of blood components 
does not appear to apply in all cancers types, it is not the case 
in patients with peritoneal colorectal carcinomatosis undergoing 
cytoreductive surgery and HIPEC. Two recently published arti-
cles both showed an independent relationship between periop-
erative blood transfusion and survival rate, especially in patients 
with high- grade mucinous neoplasms.18 19 These findings under-
line the importance of blood- sparing protocols during cytore-
ductive surgery and HIPEC. In this case report, the potential 
value of perioperative monitoring of the mitochondrial oxygen-
ation in the decision as to whether or not to transfuse a patient 
is shown. The mitochondria are the largest oxygen consumers 
within the cell. Therefore, mitoPO2 reflects the oxygen balance 
between oxygen supply and oxygen demand.20 Oxygen supply is 
dependent not only on the amount of haemoglobin but also on 
microvascular blood flow, the haemoglobin dissociation charac-
teristics, the level of oxygen saturation of haemoglobin and the 
diffusion barriers between red blood cells and the tissue cells.21 
Because so many factors are involved in maintaining an adequate 
tissue oxygenation, it doesn’t seem wise to use only haemoglobin 
levels in the decision of transfusing red blood cells. Therefore, 
we suggest to use mitoPO2 and microvascular flow measure-
ments in combination with point- of- care haemoglobin and stan-
dard operative measurements, such as blood pressure, heart rate 
and pulse oximetry, in the decision- making process for blood 
transfusion. The main goal is to reduce the number of blood 
transfusions required during oncological surgery, particularly 
during cytoreductive surgery and HIPEC and thereby improve 
Figure 1 Haemodynamics and transfusion during surgery. HR, heart 
rate; MAP, mean arterial pressure; MitoPO2, mitochondrial oxygen 
tension; rHb, recombinant haemoglobin; StO2, tissue oxygen saturation.
Learning points
 ► Transfusion is not without risk; a more individualised 
threshold for determining blood transfusion is needed.
 ► Monitoring of oxygenation at the mitochondrial level is 
clinically possible by using the delayed fluorescence of 
protoporphyrin IX.
 ► Mitochondrial oxygenation monitoring provides a new tool 
for research in resuscitation and transfusion medicine.
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the long- term outcome of the patients. The added value of the 
mitochondrial oxygenation measurements during acute periop-
erative blood loss must be demonstrated in future studies.
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